Gilead (GILD) raised at Mizuho following updated estimates
Tweet Send to a Friend
Mizuho reiterated a Buy rating on Gilead Sciences (NASDAQ: GILD) and raised their price target on the stock to $101.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


